This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
0,01155 €
Share price
-33.50%
Change (1 day)
-98.97%
Change (1 year)
Categories
Athersys (ATHX) - Total debt
Total debt on the balance sheet as of September 2023 : €15.88 Million
According to Athersys's latest financial reports the company's total debt is €15.88 Million. A company’s total debt is the sum of all current and non-current debts.
Athersys - Total debt on balance sheet (from 2006 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | €8.09 M | -6.11% |
| 2021-12-31 | €8.62 M | |
| 2016-12-31 | €0.95 M | 449.29% |
| 2015-12-31 | €0.17 M | 15.49% |
| 2014-12-31 | €0.15 M | 18.07% |
| 2013-12-31 | €0.12 M | -0.25% |
| 2012-12-31 | €0.12 M | |
| 2008-12-31 | N/A | -100% |
| 2007-12-31 | €1.22 M | |
| 2003-12-31 | €0.45 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | €49.07 B | 308,781.95% | 🇺🇸 USA |
 Pfizer PFE | €52.42 B | 329,829.48% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | €43.82 B | 275,719.56% | 🇺🇸 USA |
 Moderna
MRNA | €0.63 B | 3,910.34% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €44.69 B | 281,172.54% | 🇺🇸 USA |
 United States Lime & Minerals USLM | €4.12 M | -74.01% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |
 Merck MRK | €29.80 B | 187,465.27% | 🇺🇸 USA |
 Sanofi SNY | €19.47 B | 122,473.61% | 🇫🇷 France |